Colgate-Palmolive (NYSE:CL), a global leader in consumer products, has demonstrated resilience in the face of economic headwinds and market volatility. The company's strong brand portfolio and ...

Raymond James lowered the firm’s price target on Colgate-Palmolive (CL) to $105 from $110 and keeps an Outperform rating on the shares. The ...

James adjusted its price target for Colgate-Palmolive Company (NYSE:CL) shares, reducing it to $105 from the previous $110, while maintaining an Outperform rating. Currently trading at $86.70, near ...

Morgan Stanley lowered the firm’s price target on Colgate-Palmolive (CL) to $104 from $111 and keeps an Overweight rating on the shares. The ...

Shares of Colgate-Palmolive (NYSE: CL) pulled back today after the household products giant missed the mark on the top line ...

Colgate-Palmolive reported stable earnings for Q4 2024, beating EPS estimates but just missing revenue expectations.

CL's Q4 results show continued gains from volume and pricing, leading to organic sales growth in five of the six divisions.

Colgate announced the re-launch of Colgate Total in 2025, featuring upgraded offerings in toothpaste, manual toothbrushes, and mouthwash. Investments in data, analytics, and AI are expected to support ...

Colgate-Palmolive’s CEO noted that the company hit an “exciting milestone,” but it wasn’t enough to lift the stock premarket.

Colgate-Palmolive Co. shares are down 3.8% in premarket trades despite the toothpaste and toothbrush giant reporting better-than-expected fourth-quarter profit and hitting a full-year revenue ...